FACSX
Price
$47.91
Change
+$0.46 (+0.97%)
Updated
May 8 closing price
Net Assets
376.88M
JVMCX
Price
$24.88
Change
+$0.24 (+0.97%)
Updated
May 8 closing price
Net Assets
20.63B
Ad is loading...

FACSX vs JVMCX

Header iconFACSX vs JVMCX Comparison
Open Charts FACSX vs JVMCXBanner chart's image
Nuveen Mid Cap Value 1 C
Price$47.91
Change+$0.46 (+0.97%)
VolumeN/A
Net Assets376.88M
JHancock Disciplined Value Mid Cap C
Price$24.88
Change+$0.24 (+0.97%)
VolumeN/A
Net Assets20.63B
FACSX vs JVMCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FACSX vs. JVMCX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FACSX is a Buy and JVMCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 20.6B vs. FACSX (377M). FACSX pays higher dividends than JVMCX: FACSX (0.20) vs JVMCX (0.00). FACSX was incepted earlier than JVMCX: FACSX (26 years) vs JVMCX (14 years). FACSX (1.97) and JVMCX (1.88) have similar cost to investors . JVMCX is a more actively managed with annual turnover of: 47.00 vs. FACSX (20.00). JVMCX has a lower initial minimum investment than FACSX: JVMCX (1000) vs FACSX (2500). FACSX annual gain was more profitable for investors over the last year : -5.88 vs. JVMCX (-9.51). FACSX return over 5 years is better than : 58.67 vs. JVMCX (46.17).
FACSXJVMCXFACSX / JVMCX
Total Expense Ratio1.881.87101%
Annual Report Gross Expense Ratio1.971.88105%
Fund Existence26 years14 years-
Gain YTD-5.289-2.609203%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets377M20.6B2%
Annual Yield % from dividends0.200.00-
Returns for 1 year-5.88-9.5162%
Returns for 3 years0.932.4338%
Returns for 5 years58.6746.17127%
Returns for 10 years38.1519.98191%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPFCX17.21N/A
N/A
PGIM Jennison Focused Growth C
CNREX22.67N/A
N/A
Commonwealth Real Estate Securities
FADTX106.29N/A
N/A
Fidelity Advisor Technology A
DLACX14.02N/A
N/A
BNY Mellon Large Cap Equity Y
BSGRX12.15N/A
N/A
BlackRock Advantage Small Cap Gr R